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Figure S1. Proliferation and methods for the generation of chimeric embryos. 
Related to Figure 1. (A), Cells undergoing mitosis as revealed by phospho-histone 
H3 staining in wild type (fl/fl, upper) and mutant (D/D, lower) mESC spheroids at 48-
hours culture. Scale bars: 10 µm. (B), Quantification of mitotic index as the percentage 
of phospho-histone H3 positive cells of the total cell number in each spheroid. Mann-
Whitney Test, p=ns, number of spheroids n=34 (fl/fl), n=35 (D/D); number of 
replicates=3. (C), Comparison of the total number of cells in each spheroid. Mann-
Whitney Test, p=ns. (D), Embryos recovered at E2.5 (8-16 cells stage) from wild type 
embryos are aggregated with mESCs either wild type (fl/fl) or mutant (D/D) for Itgb1 
locus. Embryos are cultured for 24-hours in KSOM and then transferred into E2.5 
pseudo-pregnant surrogate mice. After 72-hours embryos are recovered by 
dissection. Extraembryonic lineages (ExE and VE) are derived from wild type 
embryos, while the epiblast compartment from mESCs homozygous for either the 
floxed (fl/fl) or deleted allele (D/D) of Itgb1. (E), Culture method to generate chimeric 
embryos at the expanded blastocyst stage E4.5-4.75: embryos recovered at E2.5 (8-
16 cells stage) from wild type embryos are aggregated with mESC either wild type 
(fl/fl) or mutant (D/D), cultured for 24-hours in KSOM and transferred into IVC (in vitro 
culture) medium supplemented with 10% FBS for further 24-hours. (F), Comparison 
of the total number of epiblast cells in chimeric blastocysts at E4.5-4.75 between wild 
types (Epi:fl/fl) and mutants (Epi:D/D) as refereed Figure 1 H-J: Mann-Whitney Test, 
p=ns (number of embryos n=37 (fl/fl), n=29 (D/D)). (G), Schematics of integrin 
requirement throughout development in mESCs (upper) and mouse embryos (lower). 
Integrin signalling is dispensable during early pre-implantation development 
corresponding to the in vitro state of naïve pluripotency. Conversely, signaling from 
integrin-mediated adhesion ensures survival of the epiblast upon implantation and 
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Figure S2. Loss of integrin b1 causes basal blebs but is dispensable for apico-
basal polarity establishment or basement membrane assembly. Related to 
Figure 3.  (A), Blebs are observed after 24-hours culture on the basal domain of 
mutant mESCs (arrows). (B-C), Immunofluorescences staining for the basement 
membrane (BM) components Perlecan (B) and pan-Laminins (C) at 48-hours culture. 
Mutant mESCs (Itgb1 D/D) assemble correctly the BM on the basal side, similarly to 
wild types (Itgb1 fl/fl). (D), Both wild type and mutant cells orient the Golgi apparatus 
towards the apical site. PAR6 complex is not expressed at 24-hours. (E) Assessment 
of polarity at 48-hours by the localization of PAR3. In wild type cells, PAR3 is recruited 
at apical junctions at the site of E-cadherin expression. In mutant cells, PAR3 
maintains a junctional localization, as opposed to basal PAR6 (see Figure 4H). Scale 
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Figure S3. Pharmacological treatments, impact on morphogenesis and survival. 
Related to Figure 5 and 6. (A), Supplementation of FGF2 alone does not prevent 
initiation of apoptosis in integrin b1 mutant cells (D/D): Fisher’s Exact Test: *** 
p=0.0004 (number of spheroids n=35 (fl/fl), n=39 (D/D), 3 replicate experiments). (B), 
Supplementation of FGF2 + Rock inhibitor does not prevent initiation of apoptosis in 
integrin b1 mutant cells (D/D): Fisher’s Exact Test: **** p<0.0001 (number of spheroids 
n=40 (fl/fl), n=40 (D/D), 3 replicate experiments). (C), Supplementation of IGF1 + GSK3 
inhibitor does not prevent initiation of apoptosis in integrin b1 mutant cells (D/D): 
Fisher’s Exact Test: **** p<0.0001 (number of spheroids n=38 (fl/fl), n=40 (D/D), 3 
replicate experiments). (D), Supplementation of IGF1 + GSK3 inhibitor + Rock inhibitor 
does not prevent initiation of apoptosis in integrin b1 mutant cells (D/D): Fisher’s Exact 
Test: ** p=0.0013 (number of spheroids n=39 (fl/fl), n=39 (D/D), 3 replicate 
experiments). (E) Comparison of the D/D mESCs in medium without supplementation 
vs. all conditions tested at 48-hours: from left to right Rocki alone, FGF2 alone, 
FGF2+Rocki, IGF1+GSK3i, Rocki+IGF1+GSK3i, FGF2+ IGF1+GSK3i, and complete 
supplementation with Rocki+FGF2+ IGF1+GSK3i. Treatment with each combination 
is not able to rescue the survival and does not differ from D/D mESCs in medium only 
(Fisher’s Exact Test: p=ns). Only the supplementation of the four factors together 
(Rocki+FGF2+ IGF1+GSK3i) is able to rescue the survival of the mutant mESCs (D/D 
in medium vs D/D in full supplementation: Fisher’s Exact Test: ****p<0.0001), to a 
comparable level to wild type (Figure 5D, Fisher’s Exact Test: p=ns). (F), Method of 
culture from pre- to post implantation: blastocysts are recovered at E2.5 (8-16 cells 
stage) from wild type embryos and aggregated with mESC wild type (fl/fl) or mutant 
(D/D) for Itgb1 locus. Embryos are cultured for 24-hours in KSOM in drops. Expanded 
blastocysts are moved in grid mesh in medium with increasing concentration of FBS 
supplemented as shown. FGF2, IGF1 and GSK3i are supplemented in medium after 
24-hours. ROCKi is supplemented in medium after 24-hours at 20 µM and increased 
to 40 µm during the last 48-hours culture. See methods for more details. Scale bars: 
10 µm (A-E) 
 
 
 
 
 
 
 
